Efficacy of intermittently scanned continuous glucose monitoring in patients with types 1 or 2 diabetes receiving insulin therapy: a systematic review and meta-analysis

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Systematic review shows isCGM improves HbA1c and patient satisfaction in diabetes patients, indicating its potential benefits.

isCGM significantly reduced HbA1c levels by 0.25%, improving glycemic control among patients with diabetes.
Patient satisfaction scores increased by 4.5 points with isCGM, suggesting better user experience compared to SMBG.
The study employed a systematic review and meta-analysis design involving 17 trials and 1,860 participants.
While isCGM showed benefits for HbA1c and satisfaction, it also resulted in more mild adverse events, highlighting a trade-off.

Botelho et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark